Artemis Investment Management Llp Has Decreased Mercury Sys (MRCY) Position; Integra LifeSciences Holdings (IART) Had 8 Bulls

February 15, 2018 - By Pete Kolinski

Artemis Investment Management Llp decreased Mercury Sys Inc (MRCY) stake by 30.1% reported in 2017Q3 SEC filing. Artemis Investment Management Llp sold 34,598 shares as Mercury Sys Inc (MRCY)’s stock rose 3.33%. The Artemis Investment Management Llp holds 80,339 shares with $4.17M value, down from 114,937 last quarter. Mercury Sys Inc now has $2.14 billion valuation. The stock decreased 0.11% or $0.05 during the last trading session, reaching $44.36. About 365,647 shares traded. Mercury Systems, Inc. (NASDAQ:MRCY) has risen 91.74% since February 15, 2017 and is uptrending. It has outperformed by 75.04% the S&P500.

Among 15 analysts covering Integra Lifesciences Holdings Corp. (NASDAQ:IART), 8 have Buy rating, 0 Sell and 7 Hold. Therefore 53% are positive. Integra Lifesciences Holdings Corp. had 35 analyst reports since July 29, 2015 according to SRatingsIntel. The rating was maintained by Jefferies with “Buy” on Friday, September 8. The stock of Integra LifeSciences Holdings Corporation (NASDAQ:IART) earned “Market Perform” rating by Wells Fargo on Monday, October 30. On Tuesday, May 30 the stock rating was maintained by Jefferies with “Buy”. As per Friday, July 29, the company rating was maintained by Barclays Capital. Cantor Fitzgerald maintained the shares of IART in report on Sunday, July 9 with “Buy” rating. The stock has “Buy” rating by Piper Jaffray on Monday, September 11. As per Tuesday, January 2, the company rating was downgraded by Raymond James. Citigroup initiated it with “Buy” rating and $75 target in Thursday, November 12 report. The stock has “Mkt Outperform” rating by JMP Securities on Friday, January 6. The firm earned “Sector Perform” rating on Friday, January 13 by RBC Capital Markets. See Integra LifeSciences Holdings Corporation (NASDAQ:IART) latest ratings:

08/01/2018 Broker: Barclays Capital Rating: Hold New Target: $53.0
02/01/2018 Broker: Raymond James Old Rating: Outperform New Rating: Market Perform Old Target: $55 Downgrade
02/01/2018 Broker: Bank of America Old Rating: Buy New Rating: Neutral Downgrade
09/11/2017 Broker: RBC Capital Markets Rating: Hold New Target: $50.0 Maintain
30/10/2017 Broker: Wells Fargo Old Rating: Outperform New Rating: Market Perform Downgrade
27/10/2017 Broker: J.P. Morgan Rating: Hold New Target: $44.0 Downgrade
27/10/2017 Broker: JP Morgan Old Rating: Overweight New Rating: Neutral Downgrade
10/10/2017 Broker: Jefferies Rating: Buy New Target: $58.0 Maintain
02/10/2017 Broker: RBC Capital Markets Rating: Hold New Target: $48.0 Maintain
11/09/2017 Broker: Piper Jaffray Rating: Buy New Target: $56.0 Maintain

The stock increased 1.79% or $0.89 during the last trading session, reaching $50.64. About 336,347 shares traded. Integra LifeSciences Holdings Corporation (NASDAQ:IART) has risen 32.67% since February 15, 2017 and is uptrending. It has outperformed by 15.97% the S&P500.

Investors sentiment increased to 1.29 in Q3 2017. Its up 0.15, from 1.14 in 2017Q2. It increased, as 22 investors sold Integra LifeSciences Holdings Corporation shares while 60 reduced holdings. 26 funds opened positions while 80 raised stakes. 68.21 million shares or 2.93% more from 66.26 million shares in 2017Q2 were reported. Panagora Asset invested 0% in Integra LifeSciences Holdings Corporation (NASDAQ:IART). Us Savings Bank De holds 26,977 shares or 0% of its portfolio. Bnp Paribas Arbitrage Sa owns 32,827 shares. Northern Tru reported 888,767 shares stake. 105,836 were reported by Prudential Fin. 34 are owned by Loring Wolcott & Coolidge Fiduciary Advsrs Ltd Liability Partnership Ma. Moreover, State Street Corporation has 0.01% invested in Integra LifeSciences Holdings Corporation (NASDAQ:IART). Pennsylvania-based Pnc Gp has invested 0% in Integra LifeSciences Holdings Corporation (NASDAQ:IART). Connecticut-based Aqr Cap Mngmt Limited Liability has invested 0% in Integra LifeSciences Holdings Corporation (NASDAQ:IART). State Bank Of Montreal Can stated it has 9,029 shares. Conestoga Advsr Limited Co has 0.01% invested in Integra LifeSciences Holdings Corporation (NASDAQ:IART) for 5,000 shares. First Bancorporation Of Omaha stated it has 32,652 shares or 0.1% of all its holdings. Profund Limited Co holds 0.02% or 11,268 shares. Tower Rech Capital Ltd Liability (Trc) reported 6,538 shares stake. Savings Bank Of America Corporation De reported 603,805 shares.

Integra LifeSciences Holdings Corporation develops, makes, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, orthopedics, and general surgery. The company has market cap of $3.97 billion. The firm operates through two divisions, Specialty Surgical Solutions; and Orthopedics and Tissue Technologies. It has a 82.88 P/E ratio. It offers neurosurgery and critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment.

Investors sentiment increased to 1.13 in Q3 2017. Its up 0.12, from 1.01 in 2017Q2. It improved, as 13 investors sold MRCY shares while 67 reduced holdings. 33 funds opened positions while 57 raised stakes. 45.09 million shares or 0.45% less from 45.29 million shares in 2017Q2 were reported. Usa Fin Portformulas holds 7,497 shares. Ameriprise reported 365,083 shares. Teacher Retirement System Of Texas owns 3,977 shares. Columbus Circle holds 241,765 shares. Peak6 Investments LP holds 33,238 shares or 0.01% of its portfolio. Voya Inv Management Limited Company reported 21,504 shares or 0% of all its holdings. Panagora Asset Mngmt Inc accumulated 15,491 shares or 0% of the stock. Schwab Charles holds 0.01% or 221,521 shares in its portfolio. Jpmorgan Chase And owns 0% invested in Mercury Systems, Inc. (NASDAQ:MRCY) for 40,081 shares. Beaumont Financial Prns Ltd Liability Corp holds 6,000 shares. Riverhead Mngmt Ltd Liability holds 0.02% or 6,421 shares in its portfolio. Fincl Bank Of Montreal Can stated it has 0% in Mercury Systems, Inc. (NASDAQ:MRCY). Waddell Reed Fin Inc has invested 0.2% in Mercury Systems, Inc. (NASDAQ:MRCY). Rmb Capital Mgmt Ltd Liability Company reported 97,372 shares. Ls Advsrs Ltd owns 6,457 shares for 0.02% of their portfolio.

Artemis Investment Management Llp increased Crown Holdings Inc (NYSE:CCK) stake by 132,646 shares to 368,091 valued at $21.98M in 2017Q3. It also upped Huntington Ingalls Inds Inc (NYSE:HII) stake by 36,233 shares and now owns 93,219 shares. Lauder Estee Cos Inc (NYSE:EL) was raised too.

Since September 11, 2017, it had 0 insider buys, and 10 selling transactions for $2.47 million activity. Another trade for 3,500 shares valued at $180,180 was made by THIBAUD DIDIER M C on Tuesday, January 16. The insider HAINES GERALD M II sold $119,225. 9,600 shares valued at $454,272 were sold by ASLETT MARK on Monday, September 11.

Among 9 analysts covering Mercury (NASDAQ:MRCY), 6 have Buy rating, 0 Sell and 3 Hold. Therefore 67% are positive. Mercury had 23 analyst reports since August 25, 2015 according to SRatingsIntel. The rating was initiated by SunTrust with “Buy” on Thursday, January 19. The stock of Mercury Systems, Inc. (NASDAQ:MRCY) earned “Buy” rating by Citigroup on Friday, June 10. The firm has “Hold” rating by Noble Financial given on Wednesday, January 24. Robert W. Baird maintained Mercury Systems, Inc. (NASDAQ:MRCY) on Monday, October 23 with “Buy” rating. SunTrust maintained it with “Buy” rating and $56.0 target in Wednesday, October 18 report. As per Monday, January 8, the company rating was maintained by SunTrust. Noble Financial maintained the stock with “Hold” rating in Wednesday, August 2 report. The firm has “Buy” rating given on Thursday, February 8 by Bank of America. The rating was maintained by Robert W. Baird with “Outperform” on Wednesday, October 25. The stock of Mercury Systems, Inc. (NASDAQ:MRCY) earned “Hold” rating by Jefferies on Tuesday, September 5.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Posts

>